Four Drug Pricing Executive Orders Mostly Reboot Stalled Policies

By Ariel Cohen, John Wilkerson, Michelle M. Stein / July 24, 2020 at 8:52 PM
The Trump administration on Friday (July 24) announced four executive orders that, with one exception, attempt to reboot proposals that have been languishing and that, in one case, was outright withdrawn by administration officials. The most aggressive policy -- tying Medicare Part B drug prices to those abroad -- isn’t so much a proposal as a tactic to get the drug industry to propose something else, and the order to ban drug rebates includes a poison pill. “What the president...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.